NASDAQ
IVERIC bio, Inc. (ISEE) has a free cash flow growth of -2.62% as of Friday, May 29, 2026. This represents a 89.03% increase compared to its 12-month average of -23.85%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.